Cobalt™ ICDs and CRT-Ds with BlueSync™ technology enable tablet-based programming and app-based remote monitoring, and offer exclusive algorithms to manage atrial fibrillation (AF) patients.Download Brochure
Meet Cobalt ICDs and CRT-Ds
With tablet-based programming and app-based remote monitoring, extended longevity, 40 J on all shocks, and exclusive algorithms to manage AF.
Mean longevity projections based on CareLink™ patient data.*
Option for 40 J energy delivery on all shocks, including the first.
Dual Chamber and CRT-D
Dual Chamber and CRT-D
BlueSync technology within Cobalt enables secure, wireless communication.
Tablet-based CareLink SmartSync™ device manager
Cobalt ICDs and CRT-Ds
MyCareLink Heart™ mobile app or MyCareLink Relay™ Home Communicator
CareLink network and the
Get Connected service
Manage alerts of clinically relevant events with additional CareAlert™ notifications.
Heart Failure Status:
Discover exclusive features and algorithms available in Cobalt ICDs and CRT-Ds.
These values should not be interpreted as precise numbers. Individual patient results may vary based on their specific programming and experience.
With AdaptivCRT™ programmed to BiV and LV.
Energy delivered at connector block into a 50 Ω ± 1% load.
Energy stored at charge end on capacitor.
A controlled, head-to-head study evaluating the comparative performance of device algorithms has not been done. AF detection accuracy rates determined from independent clinical trials are presented for reference.
Detection accuracy is compared using PPV, which is the percentage of all AT/AF episodes detected by the individual device detection algorithm that were adjudicated as true AT/AF.
Compared to matched control group.
Most of the reduction in AF occurred in subgroups with prolonged AV conduction at baseline and with significant left atrial reverse remodeling.
Medtronic Compia MRI™ CRT-D, Amplia MRI™ CRT-D, and Claria MRI™ CRT-D Mean Projected Service Life based on U.S. CareLink™ transmission data as of January 2019; UC201802366 EN.
Medtronic Cobalt™ HF Quad CRT-D MRI SureScan™ Model DTPB2QQ device manual.
Medtronic Evera MRI™ XT DR SureScan™ and Evera MRI™ S DR SureScan™ Mean Projected Service Life based on U.S. CareLink™ transmission data as of January 2019; UC201802366 EN.
Medtronic Cobalt™ DR MRI SureScan™ Model DDPB3D4 device manual.
Medtronic Visia AF™ VR SureScan™ Mean Projected Service Life based on U.S. CareLink™ transmission data as of January 2019; UC201802366 EN.
Medtronic Cobalt™ VR ICD MRI SureScan™ Model DVPB3D4 device manual.
Sprenger M. Comparison of Manufacturer’s AT/AF Detection Accuracy across Clinical Studies. January 2015. Medtronic data on file.
Pürerfellner H, Gillis AM, Holbrook, Hettrick DA. Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing Clin Electrophysiol. July 2004;27(7):983-992.
Ziegler PD, et al. Accuracy of Atrial Fibrillation Detection in Implantable Pacemakers. Presented at HRS 2013 (PO02-08); Denver, CO.
Medtronic data on file. QADoc DSN026170, Version 2.0, “AT/AF Duration Performance Comparison.”
Kauffman ES, Israel CW, Nair GM, et al. Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT. Heart Rhythm. August 2012;9(8):1241-1246.
Nowak B, McMeekin J, Knops M, et al. Validation of dual-chamber pacemaker diagnostic data using dual-channel stored electrograms. Pacing Clin Electrophysiol. July 2005;28(7):620-629.
Crossley GH, Padeletti L, Zweibel S, Hudnall JH, Zhang Y, Boriani G. Reactive atrial-based antitachycardia pacing therapy reduces atrial tachyarrhythmias. Pacing Clin Electrophysiol. July 2019;42(7):970-979.
Birnie D, Hudnall H, Lemke B, et al. Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: Results of the Adaptive Cardiac Resynchronization Therapy Trial. Heart Rhythm. December 2017;14(12):1820-1825.
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.